RUA Life Sciences PLC (LSE:RUA) Share Price

Company Profile

Business description
RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.
Contact
2 Drummond Crescent
Ayrshire
Scotland
IrvineKA11 5AN
GBR
T: +44 1294317073
E: [email protected]
https://www.rualifesciences.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2026
Employees
40

Recommended

Higher sales and a new loan facility increase our conviction.

Shane Ponraj, CFA | 15 January 2026

We’ve raised our fair value estimate of Taiwan Semiconductor stock.

Phelix Lee | 15 January 2026

Watching sales growth and the potential for a major acquisition, here’s what we think of Netflix stock.

Matthew Dolgin, CFA | 15 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,226.70	45.90	0.50%
CAC 40	8,272.47	40.65	-0.49%
DAX 40	25,314.25	38.14	-0.15%
Dow JONES (US)	49,442.44	292.81	0.60%
FTSE 100	10,247.66	8.72	0.09%
HKSE	26,844.96	78.66	-0.29%
NASDAQ	23,530.02	58.27	0.25%
Nikkei 225	53,936.17	174.33	-0.32%
NZX 50 Index	13,718.10	58.31	0.43%
S&P 500	6,944.47	17.87	0.26%
S&P/ASX 200	8,903.90	48.10	0.54%
SSE Composite Index	4,101.91	10.69	-0.26%